ARA290, a Specific Agonist of Erythropoietin/CD131 Heteroreceptor, Improves Circulating Endothelial Progenitors’ Angiogenic Potential and Homing Ability

Guillaume Hache, Benjamin Guillet, Youssef Bennis et al.|Shock|2016

Cited by 26